Form D · Other Investment Fund

Symbiotic Capital Life Science Credit Fund, L.P.

Los Angeles, CA · CIK 0001978089

Offering snapshot reported May 22, 2026 · SEC filing

Reported sold
$160M
Indefinite offering
Investors reported
65
Form D · investor count
Minimum accepted
$10M
Reported outside-investor minimum
First sale
Jun 5, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$80.1M$160MMay 26, 2023May 24, 2024: $99,197,062.00May 24, 2024May 23, 2025: $160,217,681.00May 23, 2025May 22, 2026: $160,217,681.00May 22, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 22, 2026Amendment$160,217,681$0vs May 23, 202565SEC filing
May 23, 2025Amendment$160,217,681$61,020,619vs May 24, 202465SEC filing
May 24, 2024Amendment$99,197,062No comparison45SEC filing
May 26, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$1.2M (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-482761
Includes sales commission of Fund and affiliated fund.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Not applicableNoneARTIST CAPITAL LLC · CRD 153937

Source: Form D, filed May 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SYMBIOTIC CAPITAL LIFE SCIENCE CREDIT FUND, L.P.

Investment adviser: SYMBIOTIC CAPITAL MANAGEMENT CO. LLC

Gross asset value
$173M
Beneficial owners
65
ADV minimum commitment
$10M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALTER DOMUS (US) LLC CHICAGO, Illinois, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ERNST & YOUNG LLP LOS ANGELES, California, United States
Custodian CITIBANK, NA NEW YORK, New York, United States Related to adviser: No
Marketer ARTIST CAPITAL LLC NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

ERNST & YOUNG LLP
PCAOB 42

CITIBANK, NA
LEI E57ODZWZ7FF32TWEFA76

ARTIST CAPITAL LLC
CRD 153937 · SEC 8-68598

Filing source

Form ADV 2079137 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-5864869798

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Arie Belldegrun Director
Himani Bhalla Director
Joshua Bradley Director
Russell Goldsmith Director
Symbiotic Capital Life Science Credit Fund Gp, L.P. Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
10100 Santa Monica Blvd, Floor 15
Los Angeles, CA, 90067